Dr. Reddys Laboratories Ltd.

Dr Reddy’s Laboratories has launched Montelukast Sodium Oral Granules, a bioequivalent generic version of Singulair (Montelukast Sodium) oral granules in the US market, following the approval by the United States Food & Drug Administration (USFDA) of its Abbreviated New Drug Application (ANDA) for Montelukast Sodium Oral Granules.

The Singulair Oral Granules brand had US sales of about $61 million for the most recent twelve months ending July 2012 according to IMS Health. The company’s Montelukast Sodium Oral Granules in 4mg are available in unit dosage package of 30.

Recently, the company launched Amoxicillin tablets Capsules and Oral Suspension, a bioequivalent generic version of Amoxil tablets, capsules and Oral Suspension in the US markets on September 17, 2012.